GBS is a nerve disease that affects senses, movements, breathing, and heartbeat in humans. The condition, in which the body’s immune system attacks nerves, can cause paralysis and even death.
Most of these injuries were either mild (leading to a median absence of 7 days or less, 6440 cases = 42%) or moderate (median absence: 7–28 days, 56% = 8518 cases) while only few (2% = 311 cases) were ...
Median time to remission was 24 weeks and median dose in remission was 30 mg. No significant safety issues were identified although tolerability appeared to decline above a dose of 40 mg with 26% ...
Where a river begins Features of a river's upper course How waterfalls, gorges and other physical features are formed Wildlife you might find near or in the upper course This resource is suitable ...
Introduction: Upper limb rehabilitation assessment plays a pivotal role in the recovery process of stroke patients. The current clinical assessment tools often rely on subjective judgments of ...
Preliminary in vivo experiments investigating muscle evoked potentials due to median nerve stimulation showed encouraging results, supporting the feasibility of increasing neural stimulation ...
Mikayla Spangler, Pharm.D., BCPS; Beth Bryles Phillips, Pharm.D., FCCP, BCPS; Mary B. Ross, M.B.A.; Kevin G. Moores, Pharm.D.
Ataxia was present in 68% of the patients with MFS/GBS and 45% of those with BBE/GBS. Antecedent illness caused by upper respiratory tract infection had occurred in 60% to 80% of these patients, and ...
The slow development of symptoms leads many patients to adapt to declining health without noticing the underlying deficiency, Shelley warned. She noted: "The most common symptom of a vitamin B12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results